HealthTrust Convenes Third Annual 340B Summit

NASHVILLE, Tenn.--(BUSINESS WIRE)--Aug 3, 2026--

HealthTrust Performance Group ™ (HealthTrust) hosted its third annual 340B Summit in Denver from July 22-23, 2026, to help members navigate the evolving 340B Drug Pricing Program, in its efforts to make healthcare missions possible.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803550152/en/

With increased compliance demands for covered entities, ongoing legal challenges and heightened scrutiny, HealthTrust members explored issues spanning legislation, drug pricing and operations that directly impact 340B program effectiveness, including:

“With 340B facing systemic change, healthcare organizations are being asked to navigate mounting policy uncertainty, operational pressures and new compliance demands all at once,” said Chris Yoder, MHA, BBM, Director, 340B Program at HealthTrust. “The 340B Summit gives members the opportunity to hear directly from a range of stakeholders shaping the program, ask important questions and gain insight that helps them respond to and anticipate change with greater clarity.”

How HealthTrust’s 340B Summit Helps Leaders

Through roundtable discussions and expert-led sessions, attendees gained practical strategies for navigating evolving 340B challenges, with a focus on compliance, operational effectiveness and protecting program value while supporting patient care. The following 340B experts from across the healthcare industry shared knowledge and firsthand perspectives with attendees:

In addition, the summit created opportunities for attendees to connect with peers and engage directly with stakeholders across the 340B ecosystem, including wholesalers and manufacturers.

The annual 340B Summit reflects HealthTrust’s broader pharmacy support for members, including resources that help strengthen pharmacy operations and advance financial and clinical performance. Learn more about the HealthTrust 340B Summit and HealthTrust’s offerings for 340B strategy and compliance here.

FAQs

What is the HealthTrust 340B Summit?

The HealthTrust 340B Summit is an annual event focused on the current and emerging challenges shaping the 340B Drug Pricing Program. It brings together healthcare leaders, manufacturers, wholesalers and industry experts to discuss the developments affecting 340B program performance.

Who can attend the HealthTrust 340B Summit?

The summit is exclusively for HealthTrust members – specifically for those involved in 340B strategy, pharmacy operations, compliance, reimbursement and broader program oversight.

What do attendees gain from the 340B Summit?

Attendees gain practical insights and strategies to help them navigate a rapidly evolving 340B environment, strengthen compliance and operational effectiveness, optimize program value and financial performance, and build meaningful industry connections.

How is the 340B landscape changing?

The 340B landscape continues to shift due to ongoing policy debates, legal disputes over contract pharmacy arrangements, increased manufacturer scrutiny and data requests, and heightened attention to compliance and program accountability. HealthTrust takes these developments into account when shaping the summit agenda each year.

Will there be a 340B Summit in 2027?

HealthTrust plans to host its annual 340B Summit again in 2027. Additional details will be shared closer to the event.

Where can I get more guidance on 340B program oversight at my organization?

Learn more about the HealthTrust 340B Summit and HealthTrust’s offerings for 340B strategy and compliance here.

About HealthTrust Performance Group

HealthTrust Performance Group ™ (HealthTrust) is a leading healthcare improvement organization owned and operated by seven health systems. Dedicated to making missions possible, HealthTrust strengthens provider performance and clinical excellence through an aligned membership model and business advisory solutions that leverage expertise, scale and innovation. Headquartered in Nashville, Tennessee, HealthTrust is the only national GPO with direct responsibility for the performance and outcomes of some of the largest healthcare supply chains—bringing a uniquely accountable perspective, supporting 25% of U.S. hospitals, including eight of the 15 largest health systems, with a membership including more than 1,900 acute care and over 90,000 non-acute care facilities across the U.S. and U.K. For five years, HealthTrust has been recognized as a Top Workplace. Learn more at healthtrustpg.com.

Chris Yoder presenting at 340B Summit

ROCHESTER, N.Y.--(BUSINESS WIRE)--Aug 3, 2026--

Token, the biometric identity assurance company, today announced the appointment of Keith Ramee as Head of Partnerships. A strategic partnerships and business development executive with more than 20 years of experience building high-impact technology ecosystems, Ramee joins Token from Yubico, where he served as Vice President of Global Partnerships and Alliances. He joins Token’s revenue organization, reporting to Chief Revenue Officer Katy Nelson, and will lead partner strategy as the company enters its next phase of growth and scale with enterprise customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803295396/en/

The appointment comes as identity becomes the control point for enterprise security. Credential compromise remains the leading cause of enterprise breaches, and AI has made the problem structurally worse — phishing, deepfakes, and social engineering now operate at machine speed, while the credentials underneath have not fundamentally changed. As enterprises move AI agents from advisory roles into operational workflows, a second question has emerged: who, exactly, approves the high-consequence actions those agents are now capable of taking? Token’s cryptographic biometric identity assurance answers both by proving the human, not just the credential — binding access and approval to a verified, physically present person through on-device biometric authentication enforced on secure hardware.

That model reaches the enterprise through partners. Token is forging alliances across identity providers, cloud platforms, technology integrations, and the global channel, and the TokenCore product line — including the TokenCore Wearable, TokenCore Portable, and TokenCore Node — is built to integrate with the IAM, SSO, and PAM infrastructure organizations already run. It does not replace the identity stack; it completes it. Ramee will own that ecosystem strategy, with responsibility for hyperscaler alliances, product integrations, and channel development as Token scales enterprise deployment.

“Enterprises are not looking for another authentication product to bolt on. They are looking for identity assurance that works inside the stack they already run,” said Kevin Surace, CEO of Token. “That happens through partners. Keith has built the kind of ecosystems that turn strong technology into a standard, and he is joining at the moment this market is ready to move.”

At Yubico, Ramee spearheaded the company’s worldwide technology alliance strategy, scaling its global program and strengthening ties with Microsoft, AWS, Okta, and Cisco while aligning product, engineering, and sales teams behind it. Across a career spanning cybersecurity, identity, and AI, he has negotiated complex agreements and launched scalable go-to-market strategies through periods of rapid expansion, acquisition, and public market exits. Most recently, he advised executive teams on ecosystem strategy and go-to-market transformation across AI, cloud, and cybersecurity partnerships. Ramee holds an MBA from the University of Southern California’s Marshall School of Business and a B.A. in Economics from Stanford University.

“Every serious security conversation now ends in the same place: organizations can no longer be certain who is on the other end of a credential,” said Ramee. “Token answers that at the hardware level, and it strengthens the identity investments enterprises have already made rather than competing with them. That combination is what makes an ecosystem worth building, and it is why I joined.”

About Token

Token provides biometric-assured identity solutions for enterprises that need to stop credential theft, phishing, social engineering, and account takeover at the point of access. Token products combine biometric fingerprint verification, secure hardware, FIDO2 and WebAuthn authentication, and wireless ease of use to ensure that only the right person can access critical systems. Token protects workforce access across modern enterprise applications, identity providers, and cloud platforms.

Founded in 2014 and backed by Grand Oaks Capital, Token delivers secure, passwordless authentication solutions that help organizations reduce identity-based risk and strengthen workforce security. For more information, visit www.tokencore.com.

Keith Ramee, Head of Partnerships, Token